The partnership with the Center of New Medicine is likely to be viewed positively by investors, as it positions QT Imaging Holdings at the forefront of personalized health care and cancer prevention. This strategic move could enhance the company's market position, potentially leading to increased investor confidence and a positive impact on its stock price in the short term.